Finally, we experimentally validated the quantified expression levels of hub genes in human breast samples and demonstrated the role of SUSD3.<h4>Conclusion</h4>These findings indicate that our lactylation risk model can be used to predict the malignant progression and immune evasion of breast cancer. This evidence concerns the gene SUSD3 and breast cancer.